Phase II Study of Irinotecan in Combination with Capecitabine on a 3-Weekly Schedule as First-Line Chemotherapy for Patients with Metastatic or Locally Advanced Colorectal Cancer. J. Anal. Oncol. [Internet]. 2013 Aug. 28 [cited 2025 Oct. 10];2(3): 151-159. Available from: https://mail.neoplasiaresearch.com/index.php/jao/article/view/80